Xavier Salvatella, ICREA researcher at IRB Barcelona, proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently available.
The incidence of prostate cancer is increasing worldwide. In the US and Europe, it is one of the most common tumours and among the main causes of death by cancer.
The European Molecular Biology Lab (EMBL) in Barcelona and IRB Barcelona bring together leading scientists in the conference “Morphogenetic Engineering”, an event supported by the BBVA Foundation.
The merge of various disciplines of developmental biology is key to enhancing our knowledge of tissue development and repair, processes that find their most direct applications in regenerative medicine.
“One day we will be able to re-build damaged organs and keep the whole body fit and healthy. But right now we must strengthen our knowledge of how tissues are built and how they are maintained,” say James Sharpe, Head of EMBL Barcelona, and Marco Milán, coordinator of the Cell and Developmental Biology programme.
Specialists advance toward the “Google Earth” of the genome, which will allow them to see the detailed structure of DNA folded within the nucleus, from atomic resolution to the level of the entire molecule
3D genomics promises to reveal the hidden layer of gene regulation and allow researchers to uncover the causes of many diseases
20 world leaders in 3D genomics will meet today until Wednesday in Barcelona at the Barcelona BioMed Conference organized by IRB Barcelona and the BBVA Foundation.
IRB Barcelona proposes activities targeted to a wide public audience during Science Week 2017.
The programme includes a visit by more than 100 school children to the centre, microtalks in pubs and debates on hot topics with well-known figures such as Andreu Mas-Colell and Isona Passola.
The activities offered by Science Week are included in the programme of the 1st ENABLE Symposium, aimed at young biomedical scientists, which will be held in Barcelona from 15 to 17 November.
From 15 to 17 November, the first international ENABLE symposium—which is fully booked—will bring together 300 PhD students and postdocs from all around Europe.
ENABLE is the first scientific symposium organised by and for young scientists and it includes scientific talks, a Career day and outreach activities.
The European Union will finance four ENABLE symposia in various European cities up to 2020.
A study published by IRB Barcelona in Nature Genetics demonstrates that the error (mutation) surveillance and repair system shows greater efficiency in the protein-coding regions of genes.
This morning Alicante has started the 100xCiencia.2 meeting, which today and tomorrow brings together the vanguard of Spanish research: the Severo Ochoa and María de Maeztu centers of excellence.
The meeting was opened by Carmen Vela, Secretary of State for Research, Development and Innovation, and she highlighted the importance of approaching science and business.
The “IRB Barcelona Futur” fellowship is funded by donations given to the permanent fundraising campaign “Futur”, which supports the training of young scientists.
The first awardee is a 24-year-old student who graduated in Biomedicine and holds a Master’s from the University of Utrecht and the Gurdon Institute in Cambridge Cambridge.
A study published in the Lancet Oncology by an international team led by Prof Rob E. Coleman (University of Sheffield) and Prof Roger R. Gomis (IRB Barcelona) identifies the effect of MAF amplification on the outcome of treatment with adjuvant zoledronic acid in early breast cancer.
This new knowledge may be key to the early detection of patients who would benefit from zoledronic acid and those who should be spared, and both reduce disease recurrence and deaths from breast cancer.
Inbiomotion, an IRB Barcelona spin off company and financed by venture investors Ysios Capital and Caixa Capital Risc, will soon start a confirmatory trial.